A small nucleolar RNA:ribozyme hybrid cleaves a nucleolar RNA target in vivo with near-perfect efficiency
AUTOR(ES)
Samarsky, Dmitry A.
FONTE
The National Academy of Sciences
RESUMO
A hammerhead ribozyme has been localized to the yeast nucleolus by using the U3 small nucleolar RNA as a carrier. The hybrid small nucleolar RNA:ribozyme, designated a “snorbozyme,” is metabolically stable and cleaves a target U3 RNA with nearly 100% efficiency in vivo. This is the most efficient in vivo cleavage reported for a trans-acting ribozyme. A key advantage of the model substrate featured is that a stable, trimmed cleavage product accumulates. This property allows accurate kinetic measurements of authentic cleavage in vivo. The system offers new avenues for developing effective ribozymes for research and therapeutic applications.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21962Documentos Relacionados
- Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect
- The effect of structure in a long target RNA on ribozyme cleavage efficiency.
- Box C/D small nucleolar RNA trafficking involves small nucleolar RNP proteins, nucleolar factors and a novel nuclear domain
- Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression.
- Ribozyme mediated destruction of RNA in vivo.
